GenomeWeb retweeted
Replying to @PrecOncNews
@PrecOncNews is hosting a virtual molecular tumor board series in February and March. In four hour-long events, experts will discuss cases dealing w/HRD, biomarker-informed off-label indications, gene fusions and the absence of targetable biomarkers event.on24.com/eventRegistra…
GenomeWeb retweeted
We are collaborating with @GenomeWeb to sponsor an upcoming webinar! Dr. Marilyn Li will present NTRK fusions in childhood tumors on September 24. Learn more and register here! hubs.li/H0vJBWZ0 #NTRK #solidtumor #fusions
GenomeWeb retweeted
The latest in our Genetic Testing Challenges Oncology series illustrates the different goals, methods, and reporting practices of labs testing for germline mutations and those testing for somatic mutations.
precisiononcologynews.com/ca…
GenomeWeb retweeted
This growing challenge of reporting presumptive germline findings from NGS tumor testing will be discussed by a panel hosted by @PrecOncNews and moderated by @EllenMatloff on June 1. Join us! genomeweb.com/resources/webi…
GenomeWeb retweeted
Replying to @GenomeWeb
@GenomeWeb #NGS webinar on June 8th by Dr. Christian Thiede from @tudresden_de entitled, "NGS-based Assessment of Hematological Malignancies: Managing a Complex Molecular Workflow" event.on24.com/eventRegistra…
GenomeWeb retweeted
In @GenomeWeb, @ATCC highlights findings from their recent #reproducability study, as well as potential solutions for improving the reproducibility problem, especially in light of the scientific community's response to the #covid19 pandemic. #clientnews https://nitter.cf/t.co/YNbIln3FsP
GenomeWeb retweeted
.@GenomeWeb sold to Crain's last year in a quiet but smart B2B transaction. Their CEO, Bernadette Toner, talks about their business in this podcast. (w/transcript for those who like to read.)
Good quick read for B2B media nerds.
fourkitchens.com/blog/digita…
GenomeWeb retweeted
As #LabWeek2020 draws to a close, AMP applauds the medical laboratory professionals working around the globe to serve patients amidst the #COVID19 pandemic. THANK YOU for all that you do! #molpath
GenomeWeb retweeted
Excellent frequently updated resource tracking all commercial COVID-19 test kits (molecular and serology) with regulatory status included. Kudos @360DxNews #Covid19testing #Covid_19
GenomeWeb retweeted
Join our Apr. 27th webinar with @GenomeWeb, ft. James Batchelor, Director of the Clinical Informatics Research Unit at the University of Southampton. Hear how using an integrated research platform gave insight into #COVID19 treatments. Register here: https://nitter.cf/t.co/F53ZtCbiLF
GenomeWeb retweeted
Will new decentralized COVID-19 tests from @CepheidNews and @AbbottNews help flatten the curve?
360dx.com/pcr/despite-potent…
GenomeWeb retweeted
.@360DxNews is updating this tracker on a regular basis in order to provide readers with up-to-date and accurate information on the regulatory status of these tests in the US, European, and Asian markets. ow.ly/XmOK50yT9Xe #COVID19 #molpath #IDTwitter
GenomeWeb retweeted
Q&A: FIND's Cassandra Kelly-Cirino Discusses COVID-19 Diagnostics Pipelines 360dx.com/pcr/qa-finds-cassa…
GenomeWeb retweeted
Precision Oncology Programs Adapting to Ensure Patient Safety, Care During Public Health Crisis precisiononcologynews.com/ca…
GenomeWeb retweeted
We're updating our #coronavirus test tracker daily with the latest tests available for diagnostic use: 360dx.com/coronavirus-test-t…
GenomeWeb retweeted
US Supreme Court Declines to Hear Case on Patent Eligibility of Diagnostics 360dx.com/policy-legislation…
GenomeWeb retweeted
GenomeWeb retweeted
Our next SOPHiA Webinar together with @GenomeWeb, entitled "Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA", will take place on January 28th starting at 11:00AM EST - Register here: https://nitter.cf/t.co/CZWYypdfQX



















